Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-24

Clinical Trial Update: Study Comparing the Safety and Efficacy of BOL-303259-X to Latanoprost in Subjects With Glaucoma or Ocular Hypertension [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing safety and efficacy of the investigational BOL-303259-X to latanoprost in adults with glaucoma or ocular hypertension; trial co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BOL-303259-X
  • Latanoprost (Latanoprost)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Intraocular Pressure | Phase 2 | Status: COMPLETED | Results posted: 2018-07-24